'1000 mg injectionc'

Gabafresh Gabapentin 1000mg Tabs - Neurontin ₹ 333 / Box Get Latest Price Product Brochure Strength 1000 mg Packaging Type Box Also gives PCD Pharma Brand Gabafresh Manufacturer Orange City Pharma Usage/Application Neuropathic pain, epilepsy Country of Origin Made in India Product Name: Gabafresh 1000mg Brand Name: Neurontin, Gabarone, Gralise Composition: Gabapentin (1000mg) Manufacturer/Marketer: Orange City Pharma Packaging: To be provided (specify packaging details if available) Treatment: Neuropathic pain, epilepsy, seizures Product Description: Gabafresh 1000mg contains Gabapentin, a medication used to treat nerve-related pain (neuropathic pain) and control certain types of seizures in epilepsy. It works by calming overactive nerve signals in the brain and nervous system, providing relief from pain and stabilizing seizure activity

C One 1000 Mg Injection ₹ 70 / Vial Get Latest Price Product Brochure Strength 1000 mg Brand Name C One Manufacturer Abbott Shelf Life 24 Months Country of Origin Made in India C One 1000mg Injection is an antibiotic belonging to the cephalosporin group, which is used to treat bacterial infections in your body. It is effective in infections of the brain (e.g., meningitis), lungs (e.g., pneumonia), ear, urinary tract, skin & soft tissues, bones & joints, blood, and heart.

Testosterone Undecanoate Injection 1000 mg Strength 1000mg/4ml Brand Cernos Drug Strength 1000mg Brand Name Cernos Depot Manufacturer Akums Drugs & Pharmaceuticals Ltd Packaging Size 4ml Ampoule Form Ampoule HSN Code 30043913 Country of Origin Made in India Cernos Depot Injection is a medicine used in the treatment of male hypogonadism caused due to low testosterone levels. It is only prescribed to men with known medical conditions. It helps in restoring the level of testosterone in the male body. Cernos Depot Injection is a testosterone replacement therapy medication used to treat male hypogonadism, a condition in which the body does not produce enough testosterone. It is a long-acting injection that is given every 10-12 weeks. Cernos Depot Injection is a safe and effective treatment for male hypogonadism, and it can help to improve symptoms such as low sex drive, fatigue, and muscle weakness. Here are some of the key features of Cernos Depot Injection: Long-acting: Cernos Depot Injection is a long-acting injection that is given every 10-12 weeks. This makes it a convenient and easy-to-use treatment option. Effective: Cernos Depot Injection is a safe and effective treatment for male hypogonadism. It has been shown to improve symptoms such as low sex drive, fatigue, and muscle weakness. Approved by the FDA: Cernos Depot Injection is approved by the FDA for the treatment of male hypogonadism. This means that it has been evaluated for safety and efficacy by a rigorous scientific process. If you are a man who is experiencing symptoms of male hypogonadism, talk to your doctor about Cernos Depot Injection. It may be the right treatment option for you. Here are some additional details about Cernos Depot Injection: It is a synthetic form of testosterone. It is injected into the muscle. It starts working within a few days of injection. It can help to improve symptoms such as low sex drive, fatigue, and muscle weakness. It is important to follow your doctor's instructions when using Cernos Depot Injection.

Valcivir 1000 Tablet should be taken in the dose and duration as advised by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. It may be taken with or without food, but it is better to take it at a fixed time. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. You should drink plenty of water while on treatment with this medicine as it helps to prevent dehydration and kidney damage.

CINKONA 300 MG 100 TAB QUININE SULPHATE ₹ 600 / Strip Get Latest Price Product Brochure Strength 300 mg Packaging Size 1*10 Prescription/Non prescription Prescription Form Tablet Shelf life 24 Months Country of Origin Made in India CINKONA 300MG TABLET contains Quinine which belongs to the group of medicines called Antimalarials. It is used to treat malaria Cinkona 300mg Tablet is an antiparasitic medicine, used for the treatment of malaria. It may also be used to treat and prevent nighttime leg cramps. It works by killing the malaria-causing parasite and stops the infection from spreading Guaranteed Delivery No Need Of Prescription Traceable Tracking will be provided on confirmed purchase Effective Pricing and Quality Best store for Cinkona 300mg

HQTOR 200 MG 100 TAB TORRENT PHARMACEUTICALS LTD ₹ 200 / Stripe Get Latest Price Product Brochure Strength 200 mg Composition Hydroxycholo sulphate Packaging Type Stripe Packaging Size 10*10 Tablets Prescription/Non prescription Prescription Brand HQTOR 200 MG Form Tablet Usage / Application Personal Country of Origin Made in India Minimum order quantity: 10 Stripe We are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our

Ivermectin 12mg Stromectol Tablet for humans ₹ 149 / Box Get Latest Price Dosage 3mg, 6mg, 12mg Packaging Type Alu-Alu Manufacturer Name Johnlee, signature, Jeerima Prescription Required Yes Composition (Salts) IVERMECTIN Usages Antiparasite Storage Conditions Room Temperature Brand IVERJOHN Ivermectin (Stromectol) is a medication used for infections caused by certain parasitic worms found in rural tropical areas. Depending on the type of worm being treated, serious side effects can occur. It hasn't been shown to work well for other types of infections.

ivermectin for humans 12mg Tablet ₹ 50 / Stripe Get Latest Price Strength 12mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

iveremectin Ivecop 6 Mg Tablet ₹ 35 / Stripe Get Latest Price Strength 6mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.